Poolbeg Pharma PLC
POLB.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £7,824 | £12,171 | £16,193 | £20,949 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £519 | £700 | £962 | £8 |
| Inventory | £0 | £0 | -£1 | £0 |
| Other Curr. Assets | £220 | £627 | £1 | £498 |
| Total Curr. Assets | £8,563 | £13,498 | £17,155 | £21,455 |
| Property Plant & Equip (Net) | £0 | £0 | £0 | £0 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £1,684 | £1,930 | £2,134 | £1,563 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £1,684 | £1,930 | £2,134 | £1,563 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £10,247 | £15,428 | £19,289 | £23,018 |
| Liabilities | – | – | – | – |
| Payables | £165 | £79 | £293 | £79 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £68 | £52 | £46 | £47 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £741 | £855 | £627 | £312 |
| Total Curr. Liab. | £974 | £986 | £966 | £438 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £0 | £0 | £0 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £974 | £986 | £966 | £438 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £4,877 | £620 |
| Common Stock | £100 | £100 | £100 | £100 |
| Retained Earnings | -£16,743 | -£10,953 | -£7,022 | -£2,336 |
| AOCI | £2,816 | £740 | -£4,877 | -£620 |
| Other Equity | £23,100 | £24,555 | £25,245 | £24,816 |
| Total Equity | £9,273 | £14,442 | £18,323 | £22,580 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £10,247 | £15,428 | £19,289 | £23,018 |
| Net Debt | -£7,824 | -£12,171 | -£16,193 | -£20,949 |